Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors

Min Wang(Sun Yat-sen University), Rui‐Hua Xu(Sun Yat-sen University), Chenyi Wu(Sun Yat-sen University), Yingnan Wang(Sun Yat-sen University), Ying Jin(Chinese Academy of Sciences), Qi Zhao(Sun Yat-sen University), Runjie Huang(Sun Yat-sen University), Feng Wang(Sun Yat-sen University), Jinling Zhang(Sun Yat-sen University), Liqin Wang(Sun Yat-sen University), Lin Tian(Sichuan University), Xiaojun Ouyang(Sun Yat-sen University), Jiajia Hu(Sun Yat-sen University), Jiaying Chen(Sun Yat-sen University), Yanxing Chen(Sun Yat-sen University)
Cancer Discovery
June 2, 2025
10.1158/2159-8290.cd-24-1033
Cited by 18

Related Papers

Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet|2023|701
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657